CELLERINO, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 1.394
AS - Asia 691
EU - Europa 672
SA - Sud America 207
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.015
Nazione #
US - Stati Uniti d'America 1.360
SG - Singapore 212
BR - Brasile 170
VN - Vietnam 168
UA - Ucraina 128
RU - Federazione Russa 117
CN - Cina 81
SE - Svezia 73
DE - Germania 69
IE - Irlanda 65
TR - Turchia 59
HK - Hong Kong 58
FR - Francia 53
DK - Danimarca 46
FI - Finlandia 36
CI - Costa d'Avorio 30
IT - Italia 30
GB - Regno Unito 27
KR - Corea 25
AR - Argentina 20
IN - India 16
BD - Bangladesh 14
MX - Messico 14
CA - Canada 11
ID - Indonesia 11
IQ - Iraq 9
MA - Marocco 7
NL - Olanda 7
JP - Giappone 6
PL - Polonia 6
ZA - Sudafrica 6
BE - Belgio 5
PK - Pakistan 5
CL - Cile 4
EC - Ecuador 4
CR - Costa Rica 3
IL - Israele 3
NP - Nepal 3
PH - Filippine 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
CO - Colombia 2
DZ - Algeria 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MR - Mauritania 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
VE - Venezuela 1
Totale 3.015
Città #
Ashburn 212
Chandler 134
Singapore 128
Jacksonville 125
Fairfield 92
Boardman 67
Dublin 65
Hong Kong 57
Hanoi 50
Wilmington 48
Dallas 45
New York 44
Ho Chi Minh City 42
Houston 41
San Jose 37
Woodbridge 35
Seattle 32
Abidjan 30
Los Angeles 30
Moscow 28
Beijing 27
Lawrence 25
Princeton 25
San Mateo 25
Ann Arbor 24
Cambridge 21
Lauterbourg 21
São Paulo 20
The Dalles 14
Hefei 13
Haiphong 12
Munich 12
Buffalo 11
Des Moines 11
Chennai 9
Helsinki 9
Orem 9
San Diego 9
Dong Ket 8
Santa Clara 8
Centro 7
Denver 7
Brasília 6
Da Nang 6
Atlanta 5
Boston 5
Campinas 5
London 5
Mexico City 5
Montreal 5
Thái Bình 5
Biên Hòa 4
Chicago 4
Curitiba 4
Frankfurt am Main 4
Guarulhos 4
Johannesburg 4
Poplar 4
Tokyo 4
Wroclaw 4
Amsterdam 3
Baghdad 3
Brussels 3
Buenos Aires 3
Cajamar 3
Calgary 3
Council Bluffs 3
Dhaka 3
Erbil 3
Guangzhou 3
Mumbai 3
Norwalk 3
Phoenix 3
Porto Alegre 3
Querétaro 3
Rio de Janeiro 3
San Francisco 3
San José 3
Sorocaba 3
Stockholm 3
Tashkent 3
Acton 2
Ankara 2
Anápolis 2
Arzano 2
Belford Roxo 2
Belo Horizonte 2
Bình Dương 2
Caruaru 2
Guayaquil 2
Hải Dương 2
Ipatinga 2
Jakarta 2
Jeddah 2
Kingston 2
Lahore 2
Latina 2
Luján 2
Maceió 2
Manaus 2
Totale 1.853
Nome #
An intronic mutation in MLH1 associated with familial colon and breast cancer. 194
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer. 147
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). 147
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment. 142
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 136
c-erbB-2 and common prognostic factors in breast cancer patients. 135
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). 132
Inadequacy of ultrasonography for monitoring response to treatment of liver metastases 128
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). 123
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system 123
A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer. 120
Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. 117
Desmoplastic small round cell tumour: a description of two cases and review of the literature 117
Locoregional treatments of unresectable liver metastases from colorectal cancer. 116
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot study. 116
Recombinant human erythropoietin in chemotherapy-associated anemia. 114
Pain and its treatment in hospitalized patients with metastatic cancer. 114
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients. 112
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. 110
Insulin-like Growth Factor (IGF) 1 and 2 help to predict disease outcome in GIST patients 107
Weekly gemcitabine and cisplatin in advanced non-small cell lung cancer: a phase II study 107
Liver metastases from colorectal cancer. 98
The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone. 97
The clinical impact of FEM regimen (5-fluorouracil, 4-epidoxorubicin and mitomycin-C) in advanced gastric cancer patients. 87
Women’s Council of the City of Senigallia, Ancona, Italy. Compliance with breast and cervical cancer screening programs in women: results from a population-based study. 84
Totale 3.023
Categoria #
all - tutte 13.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 27 39 28
2021/2022173 5 49 2 4 1 13 13 14 11 19 8 34
2022/2023352 30 50 38 24 32 34 0 22 97 2 19 4
2023/2024177 34 8 5 32 30 37 4 2 1 2 1 21
2024/2025420 48 33 20 5 36 5 49 12 92 31 32 57
2025/20261.149 96 69 77 176 175 86 162 119 97 92 0 0
Totale 3.023